(Q51494406)

5 April 2018

title

PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample. (English)

1 reference

5 April 2018

1 reference

2

1 reference

5 April 2018

Martin G Larson

8

1 reference

5 April 2018

L. Adrienne Cupples

14

1 reference

5 April 2018

Sekar Kathiresan

6

Sekar Kathiresan

1 reference

5 April 2018

1

James B Meigs

1 reference

5 April 2018

7

Stacey B Gabriel

1 reference

5 April 2018

Caroline S. Fox

5

Caroline S Fox

1 reference

5 April 2018

Christopher J O'Donnell

4

Christopher J O'Donnell

1 reference

5 April 2018

Geoffrey H Tofler

13

Geoffrey H Tofler

1 reference

5 April 2018

Peter Wilson

11

Peter W F Wilson

1 reference

5 April 2018

author name string

Chunyu Liu

3

1 reference

5 April 2018

Qiong Yang

9

1 reference

5 April 2018

Alan G Herbert

10

1 reference

5 April 2018

Dali Feng

12

1 reference

5 April 2018

publication date

1 May 2006

1 reference

5 April 2018

published in

Obesity

1 reference

5 April 2018

volume

14

1 reference

5 April 2018

issue

5

1 reference

5 April 2018

page(s)

753-758

1 reference

5 April 2018

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

Endothelial-dependent vasodilation and incidence of type 2 diabetes in a population of healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

Comprehensive Survey of Common Genetic Variation at the Plasminogen Activator Inhibitor-1 Locus and Relations to Circulating Plasminogen Activator Inhibitor-1 Levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

Plasminogen-activator inhibitor type 1 and coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

Mendelian randomization: prospects, potentials, and limitations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

Association analysis of the plasminogen activator inhibitor-1 4G/5G polymorphism in Hispanics and African Americans: the IRAS family study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

PAI-1 polymorphisms modulate phenotypes associated with the metabolic syndrome in obese and diabetic Caucasian population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

Parental transmission of type 2 diabetes: the Framingham Offspring Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

Association of C-Reactive Protein With Carotid Atherosclerosis in Men and Women: The Framingham Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

An investigation of coronary heart disease in families. The Framingham offspring study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.85

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2006.85

1 reference

5 April 2018

release_uzb2rlxlurfi5gbxabmzhzqxsi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uzb2rlxlurfi5gbxabmzhzqxsi

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16855181

1 reference

5 April 2018